等待开盘 08-01 09:30:00 美东时间
-0.008
-4.25%
Gainers Acurx Pharmaceuticals (NASDAQ:ACXP) stock moved upwards by 235.5% to $...
06-17 20:08
Drug candidate ATR12-351 has been generally safe and well-tolerated with occasional, transient, mild to moderate symptoms at application site Trial is 50% enrolled; six patients have receive...
06-17 20:02
Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it will present a poster describing the Phase 1/2 clinical
05-28 20:38
Azitra press release (NYSE:AZTR): Q1 GAAP EPS of -$0.23. Cash and cash equivalents: As of March 31, 2025, the Company had cash and cash equivalents of $3.2 million. More on Azitra Azitra enters shar...
05-14 23:35
Anitra (AMEX:AZTR) reported quarterly losses of $(0.23) per share. This is a 94.68 percent increase over losses of $(4.32) per share from the same period last year.
05-14 05:08
港股IPO观察 截止2023年的第26周,港交所1家新股上市,1家通过聆讯,2家招股,7家递交招股书。 2023年,港交所新上市公司29家,共募资163亿港元...
03-14 17:17
BRANFORD, Conn., March 12, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermat...
03-12 20:33
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_03032025_AZTR_Vandermosten.pdf
03-03 22:40
Azitra press release (NYSE:AZTR): FY Net Loss was $9 million. As of December 31, the company had cash and cash equivalents of $4.6 million. More on Azitra Seeking Alpha’s Quant Rating on Azitra Histor...
02-25 23:28
Azitra (NYSE:AZTR) on Tuesday said it has signed a securities purchase agreement with certain institutional investors to purchase 3.34 million shares of common stock at $0.2785 per share for gross pro...
02-05 04:25